RUSSELL BANKS is the new CFO for Ark Therapeutics.
Banks joins from Cephalon, where he served as European finance director for ten years.
He joins the group after David Bowyer stepped down to take a senior finance role in Zimbabwe.
“I am delighted that Russell has joined Ark, bringing as he does a wealth of experience in developing healthcare businesses both organically and through acquisition, and I have every confidence he will play a full part in helping us to meet our strategic objectives,” said Ark CEO Martyn Williams.
The group’s share price was unmoved during this morning’s trading, at 4.25p. For more company information go to the Share Price Centre.
Accountancy Age Jobs is delighted to announce the launch of a brand new look website for finance and accountancy professionals
The UK gender pay gap will not close until 2069 unless action is taken to tackle it now, according to new research by Deloitte
Three former Tesco executives, including the former finance director of Tesco UK, have been charged with fraud by the Serious Fraud Office in relation to a £263m accounting scandal at the retailer.
Deloitte chief executive David Sproul is among 11 chief executives to take part in global executive search firm Odgers Berndtson’s CEO for a Day scheme